미국의 압박 요법 시장 : 규모, 점유율 및 동향 분석(기술별, 최종 용도별, 유통 채널별), 부문별 예측(2025-2030년)
U.S. Compression Therapy Market Size, Share & Trends Analysis Report, By Technology (Static Compression Therapy, Dynamic Compression Therapy), By End Use (Hospitals), By Distribution Channel, And Segment Forecasts, 2025 - 2030
상품코드
:
1726296
리서치사
:
Grand View Research, Inc.
발행일
:
2025년 04월
페이지 정보
:
영문 100 Pages
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
미국의 압박 요법 시장 성장과 동향 :
Grand View Research, Inc.의 최신 보고서에 따르면 미국의 압박 요법 시장 규모는 2025년부터 2030년까지 연평균 복합 성장률(CAGR) 2.82%를 보이며, 2030년에는 18억 7,000만 달러에 달할 것으로 예측됩니다.
만성 정맥 부전(CVI)과 심부정맥 혈전증(DVT)과 같은 만성 정맥 질환의 비율이 증가하는 것은 압박 요법 수요를 촉진하고 있습니다.
미국 국립생물공학정보센터(National Center for Biotechnology Information 2022)에 따르면, DVT는 미국에서 20만 명 이상이 영향을 받고 있습니다. 압박 요법이 어떻게 증상을 완화하고 삶의 질을 향상시키는지 이해함으로써 도입이 촉진됩니다.
재택치료나 외래 환자 치료로의 시프트는 임상 현장 이외에도 사용할 수 있는 압박 요법 제품에 대한 수요를 높이고 있습니다. 압박 요법 제품은 환자에게 더욱 친숙해지고 있습니다.
팬데믹은 압박 요법 제품을 포함한 의료용품의 중요성에 대한 인식을 높이는 계기가 되었습니다. 작업정지, 공장폐쇄, 출하지연은 원재료나 완성품의 입수에 영향을 주었습니다.
압박 요법 시장은 식품의약국(FDA) 등의 조직이 정하는 엄격한 규제요건의 대상입니다. 압박 요법 제품에 대한 보험 적용이나 상환방침에는 일관성이 없고, 보험회사에 따라 크게 다른 경우가 있습니다.
미국의 압박 치료 시장 : 분석 개요
- 정적 압박 요법은 압박 스타킹, 슬리브, 붕대 등의 폭넓은 제품군에 의해 2024년에 기술 분야에서 우위를 차지했습니다.
- 정적 압박 요법은 다양한 환자의 요구나 상태에 대응할 수 있기 때문에 시장 우위의 요인이 되고 있습니다.
- 한편, 동적 압박 요법 분야는 가장 빠른 CAGR을 나타낼 전망입니다.
- 최종 용도별로는 병원 분야가 2024년에 31.14%의 점유율로 시장을 독점했습니다.
- 2024년에는 시설용 판매부문이 시장을 독점했습니다.
목차
제1장 분석 방법 및 범위
제2장 주요 요약
제3장 미국의 압박 요법 시장 : 변동 요인, 경향, 범위
- 시장 연관 전망
- 시장 역학
- 시장 성장 촉진요인 분석
- 시장 성장 억제요인 분석
- 시장 기회의 분석
- 시장의 과제 분석
- 미국의 압박 요법 시장 : 분석 도구
- 업계 분석 : Porter's Five Forces 분석
- PESTEL 분석
제4장 미국의 압박 요법 시장 : 기술별 추정 및 동향 분석
- 정의와 범위
- 시장 점유율 : 기술별(2024년 및 2030년)
- 부문 대시보드
- 미국의 압박 요법 시장 : 기술별 전망
- 시장 규모 예측과 동향 분석(2018-2030년)
- 정적 압박 요법
- 압박 붕대
- 착압 스타킹
- 압축 테이프
- 기타 압축 의류
- 동적 압박 요법
제5장 미국의 압박 요법 시장 : 최종 용도별 추정 및 동향 분석
- 정의와 범위
- 시장 점유율 : 최종 용도별(2024년 및 2030년)
- 부문 대시보드
- 미국의 압박 요법 시장 : 최종 용도별 전망
- 시장 규모 예측과 동향 분석(2018-2030년)
- 병원
- 전문 클리닉
- 재택치료
- 개업의
- 간병 시설
- 기타
제6장 미국의 압박 요법 시장 : 유통 채널별 추정 및 동향 분석
- 정의와 범위
- 시장 점유율 : 유통 채널별(2024년 및 2030년)
- 부문 대시보드
- 미국의 압박 요법 시장 : 유통채널별 전망
- 시장 규모 예측과 동향 분석(2018-2030년)
제7장 경쟁 구도
- 최근 동향과 영향 분석 : 주요 시장 진출기업별
- 기업/경쟁의 분류
- 벤더 상황
- 주요 유통업체 및 채널 파트너 목록
- 주요 고객
- 주요 기업의 시장 점유율 분석(2024년)
- Cardinal Health
- 3M
- SIGVARIS GROUP
- Essity
- Julius Zorn, Inc.
- HARTMANN USA, Inc
- Bauerfeind USA Inc.
- medi USA
- BIOCOMPRESSION SYSTEMS
- Gottfried Medical, Inc.
JHS
영문 목차
U.S. Compression Therapy Market Growth & Trends:
The U.S. compression therapy market size is anticipated to reach USD 1.87 billion by 2030, exhibiting a CAGR of 2.82% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising rates of chronic venous disorders, such as chronic venous insufficiency (CVI) and deep vein thrombosis (DVT), drive demand for compression therapy. Compression therapy helps manage these conditions by improving blood circulation and reducing swelling.
According to the National Center for Biotechnology Information 2022, DVT affects more than 200,000 people in the U.S. Increased awareness about the benefits of compression therapy through educational campaigns and health promotion initiatives drives consumer demand. Understanding how compression therapy can alleviate symptoms and improve quality of life encourages adoption. The growing emphasis on preventive health and self-care encourages the use of compression therapy as a proactive measure to prevent or manage chronic conditions.
The shift towards home healthcare and outpatient care increases the demand for compression therapy products that can be used outside of clinical settings. This trend includes the use of compression garments and devices at home for ongoing condition management. Home healthcare services and online purchasing options make compression therapy products more accessible to patients. Improved reimbursement policies and insurance coverage for compression therapy products help reduce financial barriers for patients and healthcare providers, which facilitates the adoption of these products.
The pandemic led to increased awareness of the importance of medical supplies, including compression therapy products. Patients recovering from severe cases of COVID-19, especially those with extended hospital stays or who experienced complications such as deep vein thrombosis (DVT), have heightened demand for compression therapy. The pandemic caused significant disruptions in global supply chains, affecting the production and distribution of compression therapy products. Lockdowns, factory closures, and shipping delays impacted the availability of raw materials and finished goods. The pandemic accelerated research and development efforts in the healthcare sector, including the development of new compression therapy solutions that address both COVID-19-related complications and other health conditions.
The compression therapy market is subject to stringent regulatory requirements set by organizations such as the Food and Drug Administration. Ensuring compliance with these regulations can be challenging and costly for manufacturers. Advanced compression therapy products, such as those with smart technology or custom fittings, can be expensive. High costs may limit accessibility for some patients and healthcare facilities. Insurance coverage and reimbursement policies for compression therapy products can be inconsistent and vary widely among insurers. This variability can create financial burdens for patients and affect market growth. The quality and effectiveness of compression therapy products available in the market vary. Manufacturers face a challenge in ensuring that all products meet high standards for performance and safety.
U.S. Compression Therapy Market Report Highlights:
- Static compression therapy dominated the technology segment in 2024 due to the broad range of products, such as compression stockings, sleeves, and bandages.
- This variety caters to different patient needs and conditions, contributing to its market dominance.
- On the other hand, the dynamic compression therapy segment is expected to grow at the fastest CAGR.
- Based on end-use, hospitals segment dominated the market with a share of 31.14% in 2024.
- In 2024, the institutional sales segment dominated the market in 2024. Due to their high patient volume, institutions such as hospitals and large clinics procure compression therapy products in bulk, which drives significant sales through institutional channels.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.3.5.1. Data for primary interviews in North America
- 1.3.5.2. Data for primary interviews in Europe
- 1.3.5.3. Data for primary interviews in Asia Pacific
- 1.3.5.4. Data for primary interviews in Latin America
- 1.3.5.5. Data for Primary interviews in MEA
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.1.1. Approach 1: Commodity flow approach
- 1.6.2. Volume price analysis (Model 2)
- 1.6.2.1. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Technology outlook
- 2.2.2. End-use outlook
- 2.2.3. Distribution channel outlook
- 2.3. Competitive Insights
Chapter 3. U.S. Compression Therapy Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Increasing prevalence of chronic vein disorders
- 3.2.1.2. Growing number of orthopedic procedures
- 3.2.1.3. Growing incidence of obesity
- 3.2.2. Market restraint analysis
- 3.2.2.1. Alternative Treatment Method
- 3.2.3. Market opportunity analysis
- 3.2.3.1. Increasing number of clinical trials
- 3.2.3.2. Technology Integration
- 3.2.4. Market challenge analysis
- 3.3. U.S. Compression Therapy Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
Chapter 4. U.S. Compression Therapy Market: Technology Estimates & Trend Analysis
- 4.1. Definitions and Scope
- 4.2. Technology Market Share, 2024 & 2030
- 4.3. Segment Dashboard
- 4.4. U.S. Compression Therapy Market by Technology Outlook
- 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.6. Static Compression Therapy
- 4.6.1. Static Compression Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6.2. Compression Bandages
- 4.6.2.1. Compression Bandages Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6.3. Compression Stockings
- 4.6.3.1. Compression Stockings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6.4. Compression Tape
- 4.6.4.1. Compression Tape Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6.5. Others Compression Garments
- 4.6.5.1. Others Compression Garments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.7. Dynamic Compression Therapy
- 4.7.1. Dynamic Compression Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.7.2. Compression Pumps
- 4.7.2.1. Compression Pumps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.7.3. Compression Sleeves
- 4.7.3.1. Compression Sleeves Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. U.S. Compression Therapy Market: End Use Estimates & Trend Analysis
- 5.1. Definitions and Scope
- 5.2. End Use Market Share, 2024 & 2030
- 5.3. Segment Dashboard
- 5.4. U.S. Compression Therapy Market by End Use Outlook
- 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.5.1. Hospitals
- 5.5.1.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5.2. Specialty Clinics
- 5.5.2.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5.3. Home Healthcare
- 5.5.3.1. Home Healthcare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5.4. Physician's Office
- 5.5.4.1. Physician's Office Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5.5. Nursing Homes
- 5.5.5.1. Nursing Homes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5.6. Others
- 5.5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. U.S. Compression Therapy Market: Distribution Channel Estimates & Trend Analysis
- 6.1. Definitions and Scope
- 6.2. Distribution Channel Market Share, 2024 & 2030
- 6.3. Segment Dashboard
- 6.4. U.S. Compression Therapy Market by Distribution Channel Outlook
- 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 6.5.1. Institutional Sales
- 6.5.1.1. Institutional Sales Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.2. Retail Sales
- 6.5.2.1. Retail Sales Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Market Participants
- 7.2. Company/Competition Categorization
- 7.3. Vendor Landscape
- 7.3.1. List of key distributors and channel partners
- 7.3.2. Key customers
- 7.3.3. Key company market share analysis, 2024
- 7.3.4. Cardinal Health
- 7.3.4.1. Company Overview
- 7.3.4.2. Financial Performance
- 7.3.4.3. Service Benchmarking
- 7.3.4.4. Strategic Initiatives
- 7.3.5. 3M
- 7.3.5.1. Company Overview
- 7.3.5.2. Financial Performance
- 7.3.5.3. Service Benchmarking
- 7.3.5.4. Strategic Initiatives
- 7.3.6. SIGVARIS GROUP
- 7.3.6.1. Company Overview
- 7.3.6.2. Financial Performance
- 7.3.6.3. Service Benchmarking
- 7.3.6.4. Strategic Initiatives
- 7.3.7. Essity
- 7.3.7.1. Company Overview
- 7.3.7.2. Financial Performance
- 7.3.7.3. Service Benchmarking
- 7.3.7.4. Strategic Initiatives
- 7.3.8. Julius Zorn, Inc.
- 7.3.8.1. Company Overview
- 7.3.8.2. Financial Performance
- 7.3.8.3. Service Benchmarking
- 7.3.8.4. Strategic Initiatives
- 7.3.9. HARTMANN USA, Inc
- 7.3.9.1. Company Overview
- 7.3.9.2. Financial Performance
- 7.3.9.3. Service Benchmarking
- 7.3.9.4. Strategic Initiatives
- 7.3.10. Bauerfeind USA Inc.
- 7.3.10.1. Company Overview
- 7.3.10.2. Financial Performance
- 7.3.10.3. Service Benchmarking
- 7.3.10.4. Strategic Initiatives
- 7.3.11. medi USA
- 7.3.11.1. Company Overview
- 7.3.11.2. Financial Performance
- 7.3.11.3. Service Benchmarking
- 7.3.11.4. Strategic Initiatives
- 7.3.12. BIOCOMPRESSION SYSTEMS
- 7.3.12.1. Company Overview
- 7.3.12.2. Financial Performance
- 7.3.12.3. Service Benchmarking
- 7.3.12.4. Strategic Initiatives
- 7.3.13. Gottfried Medical, Inc.
- 7.3.13.1. Company Overview
- 7.3.13.2. Financial Performance
- 7.3.13.3. Service Benchmarking
- 7.3.13.4. Strategic Initiatives
관련자료
